To study whether TBI alters the migration properties of adoptively transferred CD4+ T cells in a non tumor-bearing host, we applied 107 DID-fluorescently labeled Tag-Th1 cells i.p. to C3H mice 24 h after TBI in accordance with our established T cell-based immunotherapy of RIP1-Tag2 mice 6. This evidence concerns the gene CD4 and neoplasm.